Citation tools
"Continuous Administration of the Somatostatin Structural Derivative /TT-232/ by Subcutaneously Implanted Osmotic Pump Improves the Efficacy and Potency of Antitumor Therapy in Different Mouse and Human Tumor Models." Anticancer Research
28.5A
(2008):
2769-2774.
Web. 14 Feb. 2026.